Search - tctmd.com

Displaying 181 - 200 of 291

Sort: Relevancy | Date

Presentation TVT 2017

Management of Acute Coronary Syndromes and Left Main CAD in AS Patients: Case Examples and Procedural Techniques

Presenter: Raj Makkar

June 16, 2017

Presentation Fellows 2017

Left Main Disease: PCI vs CABG

Presenter: Emmanouil S. Brilakis, David E. Kandzari

April 08, 2017

Presentation CHIP Washington DC 2017

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Presenter: Gregg W. Stone

March 21, 2017

Presentation SIF 2017

Putting FFR Assessment of Left Main Disease in Perspective

Presenter: Morton J. Kern

March 10, 2017

Presentation SIF 2017

IVUS is the Preferred Invasive Modality for Guiding PCI for Unprotected Left Main Coronary Artery Disease

Presenter: Farouc A. Jaffer

March 10, 2017

Presentation CTO 2017

CTO PCI in Patients With Multivessel and Left Main Disease/Concepts of Optimal Revascularization

Presenter: Emmanouil S. Brilakis, Gerald S. Werner, Robert W. Yeh

February 23, 2017

Presentation TCT 2016

Case Conclusion: How Did I Treat?

Presenter: Runlin Gao, Bo Xu, Kefei Dou

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 2)

Presenter: Runlin Gao, Bo Xu, Zening Jin

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 1)

Presenter: Runlin Gao, Bo Xu, Philippe Généreux

November 01, 2016

Presentation TCT 2016

Case Introduction: How Should I Treat?

Presenter: Runlin Gao, Bo Xu, Kefei Dou

November 01, 2016

Presentation TCT 2016

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered!

Presenter: Robert A. Guyton, Martin B. Leon, Marc Ruel

October 31, 2016

Presentation TCT 2016

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes the Issue Is No Longer in Doubt!

Presenter: Robert A. Guyton, Martin B. Leon, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Case #2: STEMI in Patient With Left Main and Multivessel Disease

Presenter: Graham A. Cassel, Narek Zakaryan

October 31, 2016

Presentation TCT 2016

Trends in Outcomes of Treatment for LM Artery Disease: IRIS-MAIN Registry Data (N=5,020)

Presenter: Seung-Jung Park, Alan C. Yeung

October 31, 2016

Presentation TCT 2016

EXCEL Outcomes in Patients With and Without Chronic Kidney Disease

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Joseph F. Sabik

October 31, 2016

Presentation TCT 2016

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

Presenter: Sorin J. Brener, Jean-François Tanguay, Rafael Cavalcante

October 31, 2016

Presentation TCT 2016

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Presenter: Thomas F. Luscher, Patrick W. Serruys, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

TCT 47: Secular Trends in Characteristics, Treatments, and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Over Two Decades

Presenter: Javier Escaned, Christoph K. Naber, Duk-Woo Park

October 31, 2016

Presentation TCT 2016

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Evald H. Christiansen

October 31, 2016

Presentation TCT 2016

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Gregg W. Stone

October 31, 2016

Advertisement

Management of Acute Coronary Syndromes and Left Main CAD in AS Patients: Case Examples and Procedural Techniques

Left Main Disease: PCI vs CABG

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Putting FFR Assessment of Left Main Disease in Perspective

IVUS is the Preferred Invasive Modality for Guiding PCI for Unprotected Left Main Coronary Artery Disease

CTO PCI in Patients With Multivessel and Left Main Disease/Concepts of Optimal Revascularization

Case Conclusion: How Did I Treat?

How Would I Treat? (Option 2)

How Would I Treat? (Option 1)

Case Introduction: How Should I Treat?

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered!

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes the Issue Is No Longer in Doubt!

Case #2: STEMI in Patient With Left Main and Multivessel Disease

Trends in Outcomes of Treatment for LM Artery Disease: IRIS-MAIN Registry Data (N=5,020)

EXCEL Outcomes in Patients With and Without Chronic Kidney Disease

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

TCT 47: Secular Trends in Characteristics, Treatments, and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Over Two Decades

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content